Clinical technology and evidence-based solutions provider Wolters Kluwer, Health, has been recognized by Frost & Sullivan with a 2021 New Product Innovation Award for its ‘state-of-the-art suite of clinical surveillance solutions that contribute to vastly improved patient outcomes and measurable reductions in the cost of care.’
According to Victor Camlek, Principal Analyst for Frost & Sullivan’s global Healthcare & Life Sciences team, Wolters Kluwer is developing an innovative mix of clinical surveillance solutions that are highly focused on optimizing alert performance and data analytics. As large integrated hospital systems attempt to operate a consistent clinical program across diverse electronic health records, the solution’ advanced technology platform allows for the centralized standardization of clinical initiatives to optimize performance.
Every minute counts for patients at risk of developing sepsis or healthcare-associated infections. Wolters Kluwer’s artificial intelligence (AI)-enabled technology and evidence-based algorithms allow its Sentri7® and POC Advisor™ offerings to enable clinical interventions with the right care at the right time to improve patient outcomes. The company’s renowned clinical content from Lexicomp and UpToDate is directly integrated into its advanced clinical surveillance solutions, giving health systems a complete solution supported by evidence-based content, not just alerts.
Click here to read the original press release.
